Top of page
Global Site Navigation

School of Medical and Health Sciences

Local Section Navigation

Help us improve our content by rating this page.

Page rating system

Please leave a comment about your rating so we can better understand how we might improve the page.

You are here: Main Content

Dr Elin Gray

Senior Lecturer

Contact Information Telephone: +61 8 6304 2756, Mobile: 0406840197, Email: e.gray@ecu.edu.au, Campus: Joondalup, Room: JO17.309
Staff Member Details
Telephone: +61 8 6304 2756
Mobile: 0406840197
Email: e.gray@ecu.edu.au
Campus: Joondalup  
Room: JO17.309  

 

Elin is a Postdoctoral Research Fellow in Melanoma within the School of Medical and Health Sciences.

Background

Dr Elin Gray is a Cancer Research Trust Postdoctoral Fellow and Senior Researcher at the Melanoma Research Group, within the School of Medical and Health Sciences at ECU. Prior to appointment at ECU, Elin worked at the National Institute for Communicable Diseases in South Africa; the Vaccine Research Center at the NIH, USA and the Duke Human Vaccine Institute, Duke University, USA. Elin’s previous research focused in immunology and virology before relocating to Edith Cowan University in 2011. Dr Gray current research aims to  identify blood biomarkers for diagnosis of melanoma and to guide treatment decisions. Her team utilises and develops novel genetic analysis methodologies to interrogate biomarkers such as circulating tumour cells, circulating tumour DNA and exosomes, to provide information on the tumour evolution and cancer development. In addition, Elin is interested in identifying mechanisms of drug resistance and developing better treatment strategies. Dr Gray works in close collaboration with leading oncologists and pathologists to translate these results into clinical application.

Qualifications

  • PhD (Doctoral Degree), South Africa, 2008.
  • M (Master Degree), Cuba, 2001.
  • B (Bachelor Degree), Cuba, 1997.

Research

Recent Research Grants

  • Liquid biopsy for personalised monitoring of melanoma patients ,  National Health and Medical Research Council,  Development Grants,  2017 - 2020,  $950,389.
  • Characterisation of Melanoma Circulating Tumour Cells for Personalised Treatment,  Cancer Research Trust,  Postdoctoral Fellowship,  2014 - 2019,  $830,000.
  • Predictive significance of circulating tumour cells (CTCs), circulating tumour DNA (ctDNA) and serum vascular endothelial growth factor (VEGF) in advanced melanoma patients treated with pembrolizumab,  Merck Sharp and Dohme (Australia) Pty Ltd,  Grant,  2016 - 2018,  $73,300.
  • Genetic Analysis of Blood Markers for Prognosis in Patients with Uveal Melanoma,  University of Western Australia,  Raine Foundation Grant,  2016 - 2018,  $100,000.
  • Circulating Tumour DNA to Predict and Monitor Treatment Response and Detect Acquired Resistance in Patients with Metastatic Melanoma,  Ramaciotti Foundation,  Grant,  2015 - 2018,  $99,911.
  • Understanding the Role of Melanoma Exosomes in Intercellular Communication,  Cancer Council of WA Inc,  Collaborative Cancer Grant Scheme,  2017 - 2018,  $43,230.
  • Blood based biomarkers predictive of treatment efficacy in metastatic melanoma,  Spinnaker Health Research Foundation,  Collaborative Research Partnership Grants,  2017 - 2018,  $107,448.
  • Blood Based Biomarkers Predictive of Treatment Response in Melanoma,  Cancer Council of WA Inc,  Grant,  2016 - 2018,  $246,822.
  • A Blood Based `Liquid Biopsy? to Improve Healthcare for Metastatic Melanoma Patients,  Department of Health WA,  SHRAC Research Translation Projects,  2016 - 2018,  $4,075,030.
  • Using a Functional Protein Array to Identify Autoantibody Biomarkers with Diagnostic Potential for Melanoma,  National Health and Medical Research Council,  Development Grants,  2014 - 2017,  $778,368.
  • NHMRC Fellowship 'near-miss' funding,  Department of Health WA,  Near Miss Merit Awards,  2016 - 2017,  $50,000.
  • Western Australia Single-Cell Isolation and Genomics Preparation Facility,  Australian Research Council,  Grant - Linkage (Infrastructure),  2017,  $430,000.
  • Circulating Melanoma Cells as Predictive Biomarkers of Treatment Response and Disease Status,  Cancer Council of WA Inc,  Grant,  2015 - 2017,  $111,519.
  • Gene expression profiling of circulating tumour cells (CTCs) isolated from metastatic melanoma patients using a microfluidic chip,  Cancer Council of WA Inc,  Grant - Early Career Investigator,  2016 - 2017,  $35,000.
  • New Independent Research Infrastructure Support Award 2016,  Department of Health WA,  New Independent Researcher Infrastructure Support (NIRIS) Awards,  2016 - 2017,  $10,000.
  • Mass Cytometry: A breakthrough in multidimensional systems biology,  Australian Research Council,  Grant - Linkage (Infrastructure),  2015 - 2016,  $1,081,489.
  • A Single-Molecule Super-Resolution Microscopy Facility in Western Australia,  Australian Research Council,  Grant - Linkage (Infrastructure),  2016,  $2,094,000.
  • Melanoma Mutation Profiling For Personalised Treatment,  National Health and Medical Research Council,  Project Grants,  2013 - 2016,  $765,359.
  • Circulating Tumour Cells (CTCs) as a diagnostic tool to monitor disease progression in melanoma patients,  Edith Cowan University,  ECU Industry Collaboration Grant - 2015 (Round 1),  2015 - 2016,  $137,227.
  • Transcriptomic profiling of Circulating Tumour Cells (CTCs) isolated from metastatic melanoma patients,  Edith Cowan University,  School of Medical and Health Sciences Research Grant Scheme 2016,  2016,  $10,000.
  • Genetic Analysis of Melanoma Cells in Blood For Personalised Treatment Management,  Edith Cowan University,  ECU Early Career Researcher Grant - 2013,  2013 - 2014,  $24,083.
  • Detection of Vemurafenib Resistance in Circulating Tumour Cells for Personalised Treatment of Melanoma,  Harry Perkins Institute of Medical Research,  Scott Kirkbride Melanoma Research Centre - Discovery Research Priming Grant,  2013 - 2014,  $68,182.
  • Detection of stem cell markers expression in circulating melanoma cells using multiparameter flow cytometry as a prognosis tool,  Edith Cowan University,  ECU Early Career Researcher Grant - 2012 (Round 1),  2012 - 2013,  $19,480.
  • Expanding Capacity and Capability in Western Australian Flow Cytometry for Earth, Oceans, Environmental and Biomedical Science: State-of-the-Art Four Laser and 12 Colour Analysis,  Australian Research Council,  Grant - Linkage (Infrastructure),  2012 - 2013,  $598,000.
  • Neon Transfection System and Biomedical Research Grade -30oC Freezer for Alzheimer?s and Melanoma Research,  National Health and Medical Research Council,  Equipment Grant 2011,  2011 - 2012,  $10,927.

Recent Publications (within the last five years)

Book Chapters

  • Freeman, J., Gray, E., Ziman, M., (2015), Circulating Tumor Cells as Biomarkers in Cancer. Biomarkers in Cancer, 31-51, London, UK, DOI: 10.1007/978-94-007-7681-4_21.

Journal Articles

  • Calapre, L., Gray, E., Kurdykowski, S., David, A., Descargues, P., Ziman, M., (2017), SIRT1 activation mediates heat-induced survival of UVB damaged Keratinocytes. BMC Dermatology, 17(8), 10p., DOI: 10.1186/s12895-017-0060-y.
  • Aya-Bonilla, C., Marsavela, G., Freeman, J., Lomma, C., Frank, M., Khattak, M., Tarek, M., Millward, M., Warkiani, M., Gray, E., Ziman, M., (2017), Isolation and detection of circulating tumour cells from metastatic melanoma patients using a slanted spiral microfluidic device. Oncotarget, In Press(In Press), 15p..
  • Calapre, L., Gray, E., Kurdykowski, S., David, A., Hart, P., Descargues, P., Ziman, M., (2016), Heat-mediated reduction of apoptosis in UVB-damaged keratinocytes in vitro and in human skin ex vivo. BMC Dermatology, 16(1), Article no. 6, London, UK, DOI: 10.1186/s12895-016-0043-4.
  • Zaenker, P., Gray, E., Ziman, M., (2016), Autoantibody Production in Cancer?The Humoral Immune Response toward Autologous Antigens in Cancer Patients. Autoimmunity Reviews, 15(5), 477-483, DOI: 10.1016/j.autrev.2016.01.017.
  • Bandawe, G., Moore, P., Werner, L., Gray, E., Sheward, D., Madiga, M., Nofemela, A., Thebus, R., Marais, J., Maboko, L., Karim, S., Hoelscher, M., Morris, L., Williamson, C., (2015), Differences in HIV type 1 neutralization breadth in 2 geographically distinct cohorts in Africa. Journal of Infectious Diseases, 211(9), 1461-1466, DOI: 10.1093/infdis/jiu633.
  • Richardson, S., Gray, E., Mkhize, N., Sheward, D., Lambson, B., Wibmer, C., Masson, L., Werner, L., Garrett, N., Passmore, J., Karim, Q., Karim, S., Williamson, C., Moore, P., Morris, L., (2015), South African HIV?1 subtype C transmitted variants with a specific V2 motif show higher dependence on a?4?7 for replication. Retrovirology, 12(1), Article no. 54, DOI: 10.1186/s12977-015-0183-3.
  • Richardson, S., Gray, E., Mkhize, N., Sheward, D., Lambson, B., Wibmer, CK., Masson, L., Werner, L., Garrett, N., Passmore, J., Abdool Karim, Q., Abdool Karim, S., Williamson, C., Moore, P., Morris, L., (2015), South African HIV-1 subtype C transmitted variants with a specific V2 motif show higher dependence on a?4?7 for replication. Retrovirology , 12(54), Article Number 54, DOI: 10.1186/s12977-015-0183-3.
  • Moody, A., Gao, F., Gurley, T., Amos, J., Kumar, A., Hora, B., Marshall, D., Whitesides, J., Xia, S., Parks, R., Lloyd, K., Hwang, K., Lu, X., Bonsignori, M., Finzi, A., Vandergrift, N., Alam, M., Ferrari, G., Shen, X., Tomaras, G., Kamanga, G., Cohen, M., Sam, N., Kapiga, S., Gray, E., Tumba, N., Morris, L., Zolla-Pazner, S., Gorny, M., Mascola, J., Hahn, B., Shaw, G., Sodroski, J., Liao, H., Montefiori, D., Hraber, P., Korber, B., Haynes, B., (2015), Strain-Specific V3 and CD4 Binding Site Autologous HIV-1 Neutralizing Antibodies Select Neutralization-Resistant Viruses. Cell Host and Microbe, 18(3), 354-362, DOI: 10.1016/j.chom.2015.08.006.
  • Gray, E., Reid, A., Bowyer, S., Calapre, L., Siew, K., Pearce, R., Cowell, L., Frank, M., Millward, M., Ziman, M., (2015), Circulating Melanoma Cell Subpopulations: Their Heterogeneity and Differential Responses to Treatment. Journal of Investigative Dermatology, 135(8), 2040-2048, London, United Kingdom, DOI: 10.1038/jid.2015.127.
  • Reid, A., Freeman, J., Millward, M., Ziman, M., Gray, E., (2015), Detection of BRAF-V600E and V600K in melanoma circulating tumour cells by droplet digital PCR. Clinical Biochemistry, 48(15), 999-1002, Philadelphia, USA, DOI: 10.1016/j.clinbiochem.2014.12.007.
  • Gray, E., Rizos, H., Reid, A., Boyd, S., Pereira, M., Lo, J., Tembe, V., Freeman, J., Lee, J., Scolyer, R., Siew, K., Lomma, C., Cooper, A., Khattak, M., Meniawy, T., Long, G., Carlino, M., Millward, M., Ziman, M., (2015), Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma. Oncotarget, 6(39), 42008-42018, New York, USA, DOI: 10.18632/oncotarget.5788.
  • Klinac, D., Gray, E., Freeman, J., Reid, A., Bowyer, S., Millward, M., Ziman, M., (2014), Monitoring changes in circulating tumour cells as a prognostic indicator of overall survival and treatment response in patients with metastatic melanoma. BMC Cancer, 14(1), Article number 423, United Kingdom, DOI: 10.1186/1471-2407-14-423.
  • Alexandre, K., Moore, P., Nonyane, M., Gray, E., Ranchobe, N., Chakauya, E., McMahon, J., O'Keefe, B., Chikwamba, R., Morris, L., (2013), Mechanisms of HIV-1 subtype C resistance to GRFT, CV-N and SVN. Virology, 446(1-2), 66-76, DOI: 10.1016/j.virol.2013.07.019.
  • Moore, PL., Sheward, D., Nonyane, M., Ranchobe, N., Hermanus, T., Gray, E., Karim, SS., Williamson, C., Morris, L., (2013), Multiple pathways of escape from HIV broadly cross-neutralizing V2-dependent antibodies. Journal of Virology, 87(9), 4882-4894, United States, DOI: 10.1128/JVI.03424-12.
  • Lacerda, M., Moore, P., Ngandu, N., Seaman, M., Gray, E., Murrell, B., Krishnamoorthy, M., Nonyane, M., Madiga, M., Wibmer, C., Sheward, D., Bailer, R., Gao, H., Greene, K., Karim, S., Mascola, J., Korber, B., Montefiori, D., Morris, L., Williamson, C., Seoighe, C., (2013), Identification of broadly neutralizing antibody epitopes in the HIV-1 envelope glycoprotein using evolutionary models. Virology Journal, 10(Article no. 347), 18 p., London, United Kingdom, DOI: 10.1186/1743-422X-10-347.
  • Wibmer, C., Bhiman, J., Gray, E., Tumba, N., Abdool Karim, SS., Williamson, C., Morris, L., Moore, P., (2013), Viral Escape from HIV-1 Neutralizing Antibodies Drives Increased Plasma Neutralization Breadth through Sequential Recognition of Multiple Epitopes and Immunotypes. PLoS Pathogens, 9(10), 16p., United States, DOI: 10.1371/journal.ppat.1003738.
  • Calapre, L., Gray, E., Ziman, M., (2013), Heat stress: a risk factor for skin carcinogenesis. Cancer Letters, 337(1), 35-40, Ireland.
  • Klinac, D., Gray, E., Milward, M., Ziman, M., (2013), Advances in personalized targeted treatment of metastatic melanoma and non-invasive tumor monitoring. Frontiers in Oncology, 3(March 2013), Article 00054, DOI: 10.3389/fonc.2013.00054.
  • Freeman, J., Gray, E., Milward, M., Pearce, R., Ziman, M., (2012), Evaluation of a multi-marker immunomagnetic enrichment assay for the quantification of circulating melanoma cells. Journal of Translational Medicine, 10(1), art. no. 192 , United Kingdom, DOI: 10.1186/1479-5876-10-192.
  • Moore, P., Gray, E., Wibmer, CK., Bhiman, J., Nonyane, M., Sheward, D., Hermanus, T., Bajimaya, S., Tumba, N., Abrahams, M., Lambson, B., Ranchobe, N., Ping, L., Ngandu, N., Karim, Q., Karim, S., Swanstrom, R., Seaman, M., Williamson, C., Morris, L., (2012), Evolution of an HIV glycan?dependent broadly neutralizing antibody epitope through immune escape. Nature Medicine, 18(11), 1688-1692, DOI: 10.1038/nm.2985.
  • Alexandre, K., Gray, E., Mufhandu, H., McMahon, J., Chakauya, E., O'Keefe, B., Chikwamba, R., Morris, L., (2012), The lectins griffithsin, cyanovirin-N and scytovirin inhibit HIV-1 binding to the DC-SIGN receptor and transfer to CD4+ cells. Virology, 423(2), 175-186.
  • Archary, D., Rong, R., Gordon, M., Boliar, S., Madiga, M., Gray, E., Dugast, A., Hermanus, T., Goulder, P., Coovadia, H., Werner, L., Morris, L., Alter, G., Derdeyn, C., Ndung'u, T., (2012), Characterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infection. Virology, 433(2), 410-420, DOI: 10.1016/j.virol.2012.08.033.
  • Mufhandu, H., Gray, E., Madiga, M., Tumba, N., Alexandre, K., Khoza, T., Wibmer, C., Moore, P., Morris, L., Khati, M., (2012), UCLA1, a synthetic derivative of a gp120 RNA aptamer, inhibits entry of human immunodeficiency virus type 1 subtype C. Journal of Virology, 86(9), 4989-4999, DOI: 10.1128/JVI.06893-11.
  • Lynch, R., Tran, L., Louder, M., Schmidt, S., Cohen, M., Dersimonian, R., Euler, Z., Gray, E., Karim, S., Kirchherr, J., Montefiori, D., Sibeko, S., Soderberg, K., Tomaras, G., Yang, Z., Nabel, G., Schultemaker, H., Morris, L., Haynes, B., Mascola, J., (2012), The Development of CD4 Binding Site Antibodies during HIV-1 Infection. Journal of Virology, 86(14), 7588-7595, DOI: 10.1128/JVI.00734-12.

Conference Publications

  • Maurya, D., Fooladvand, M., Gray, E., Ziman, M., Alameh, K., (2015), Lab-on-chip platform for circulating tumor cells isolation. Micro+Nano Materials, Devices, and Systems, 9668(6-9 Dec, 2015), 9668-34, Sydney, Australia.

Research Student Supervision

Principal Supervisor

  • Master of Science (Human Biology),  Genetic Markers In Circulating Tumour Cells As A Measure Of The Metastatic Propensity Of Uveal Melanoma

Associate Supervisor

  • Doctor of Philosophy,  Heat Stress: A Risk Factor For Skin Carcinogenesis
Skip to top of page